Background: Lung cancer is the leading cause of cancer death worldwide. Routine
| INTRODUC TI ON
Lung cancer is the leading cause of cancer-related death worldwide. 1 Five-year cancer survival rapidly decreases the later lung cancer is diagnosed, due to limited treatments options. In the UK, when lung cancer is diagnosed at the earliest stage (Stage I), 56% of patients can expect to survive for one year or more, in comparison with 14% of patients diagnosed at the most advanced stage (Stage IV). 2 With 78% of UK non-small-cell lung cancer cases diagnosed in the later stages of disease (Stage III or IV), 2 there is a need to explore strategies to diagnose lung cancer earlier.
Currently, diagnostic testing for suspected lung cancer in the UK requires symptomatic patients to present to a healthcare professional for referral for further investigation. This approach relies on the patient and healthcare professional accurately appraising symptoms, which may be problematic for early diagnosis of lung cancer. 3 Lung cancer symptoms are hard to detect in the early stages, due to misattribution to smoking habit, comorbidities or other benign causes. 4, 5 Evidence suggests that low-dose computed tomography (CT) screening is effective in detecting early-stage lung cancer. 6 The US National Lung Screening Trial reported a 20% reduction in lung cancer mortality 6 and is currently the standard of care in the United States. 7 Although not routinely available in the UK, trials are ongoing across Europe to assess the effectiveness of CT lung screening among high-risk groups. [8] [9] [10] [11] In the event that lung screening for high-risk populations is introduced routinely in the UK, it is important to understand the barriers to participation and develop interventions to encourage those who are eligible to engage in lung screening in order to optimize its impact and maintain cost-effectiveness.
Previous studies of attitudes towards lung cancer screening suggest that smokers from socio-economically deprived groups place lower value on the benefits of lung cancer screening, hold fatalistic beliefs about lung cancer as an untreatable disease or report stigma as a barrier to screening participation. 12, 13 In addition, emotional barriers such as fear of lung cancer 14 Pre-campaign survey data were collected from a total of 1007 adults. The number of people who declined to participate was not recorded, thus the characteristics of survey decliners are unknown.
| Design/procedure
The survey used random quota sampling based on neighbourhoods classified according to census characteristics. The Omnibus sample is designed to be representative of the adult population resident in Wales aged 16 and over, with Lower Layer Super Output Area (LSOA)
as the unit of sampling. Sixty-nine interviewing points throughout Wales were selected with probability proportional to resident population, after stratification by local authority and social group based on occupation. Social group was recorded in four categories using the National Readership Survey grades, based on the occupation of the household's chief income earner: AB (higher and intermediate managerial, administrative and professional), C1 (supervisory, clerical and junior managerial, administrative and professional), C2
(skilled manual workers) and DE (semiskilled and unskilled manual workers, state pensioners, casual and lowest grade workers, and unemployed with state benefits only). Categories were combined to cluster participants by social group: ABC1 participants were considered high socio-economic status, and the C2DE participants were considered low socio-economic status.
Within each sampling point, quota sample controls of age and social group within gender were set for the selection of respondents.
Quotas were set to reflect the individual demographic profile of each 19 Lung cancer beliefs were assessed with four items:
| Measures
"I would not want to know if I had lung cancer" reflecting can- with strongly agree and agree combined to create "agree," disagree and strongly disagree combined to create "disagree." "Don't know" responses were counted as missing.
| Statistical analysis
Descriptive statistics were used to summarize the demographic characteristics of the sample and to assess missing and "don't know"
responses. Chi-square univariable tests were used to examine the influence of smoking history, age, gender, social group and lung cancer beliefs on endorsement of attitudes to individual lung cancer screening items. Multivariable regression modelling was carried out to examine the influence of smoking history and lung cancer beliefs on lung cancer screening attitudes (individual items), adjusting for age, gender, social group combined and prior exposure to lung cancer messages. The significance level was set at P < 0.01 to adjust for multiple testing. To account for nonrepresentativeness, a weight was applied to the data based on age and gender within local authority in Wales.
| RE SULTS
Of a total of 1007 participants, 295 (29%) were aged [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] 328 (33%) aged 33-54 and 383 (38%) aged over 55 (see Table 1 ). There were 518 females (51%) and 489 males (49%), with 406 (41%) from the social group ABC1 and 596 (60%) from the social group C2DE.
Most of the sample had never smoked (n = 433, 43%), 286 (28%) used to smoke, 259 (26%) currently smoked up to 20 cigarettes a day and 28 (3%) currently smoked more than 20 cigarettes a day (see Table 1 ). For univariable and multivariable analysis purposes, "smoke up to 20 a day" and "smoke over 20 a day" were combined to create a "currently smoke" category.
TA B L E 1 Participant characteristics

| Univariate analysis
| Avoidance of lung screening
Fifteen per cent (n = 144) of the sample endorsed avoidance of lung screening due to fear of what might be found (Figure 1 ). Avoidance of lung screening was statistically significantly associated with fatalism (P ≤ 0.001), low perceived value of symptom presentation (P ≤ 0.001), having negative views about treatment (P ≤ 0.001) and worry about wasting the doctor's time (P ≤ 0.001) (see Table 2 ).
Associations between lung screening attitudes and age, gender, social group, smoking status and exposure to lung messages were not statistically significant.
| Low perceived effectiveness of lung screening
A total of 8% (n = 78) endorsed low perceived effectiveness of lung screening (see Figure 1 ). Low perceived effectiveness of lung screening was statistically significantly associated with fatalism (P ≤ 0.001), low perceived value of symptom presentation (P ≤ 0.001), having negative views about treatment (P ≤ 0.001) and worry about wasting the doctor's time (P ≤ 0.001) (see Table 3 ). Effects of age, gender, smoking status, social group and exposure to lung messages were not statistically significant.
| Lung screening to reduce mortality
Ninety per cent (n = 859) of the sample agreed that lung screening could reduce chances of lung cancer death (Figure 1 ). Agreeing that lung screening could reduce chances of dying from cancer was associated with positive lung cancer beliefs reflecting lack of fatalism (P ≤ 0.001) and having positive views about treatment (P ≤ 0.001) (see Table 4 ). There were no statistically significant effects of any demographic variables.
| Logistic regression
Regression analysis was completed using the weighted data, adjusting for age, gender, social group and previous exposure to lung messages.
| Avoidance of lung screening
Negative lung cancer beliefs including fatalism (aOR = 8.8 CI = 5.6-13.9, P ≤ 0.001), low perceived value of symptom presentation (aOR = 2.4, CI = 1.5-3.9, P ≤ 0.001) and having negative views about treatment (aOR = 0.3, CI = 0.2-0.7, P ≤ 0.01) showed a statistically significant association with not wanting to have lung screening due to being worried about what might be found (see Table 5 ). Smoking status and being worried about wasting the doctor's time were not statistically significantly associated with lung cancer screening avoidance due to worry about the outcome.
| Low perceived effectiveness of lung screening
Negative lung cancer beliefs including fatalism (aOR = 6.4 CI = 3.5-11.7, P ≤ 0.001), low perceived value of symptom presentation (aOR = 4.9, CI = 2.7-8.9, P ≤ 0.001) and having negative views about treatment (aOR = 0.1, CI = 0.1-0.3, P ≤ 0.001) showed a statistically significant association with low perceived effectiveness of lung screening (see Table 5 ). Smoking status and being worried about wasting the doctor's time were not statistically significantly associated with attitudes towards the efficacy of screening. Lung screening could reduce my chances of dying from cancer I don't think there is any point going for lung cancer screening because it won't affect the outcome I would be so worried what might be found at lung cancer screening that I would prefer not to go Agree Disagree (aOR = 6.1, 95% CI = 3.0-12.6, P ≤ 0.001) showed a statistically significant association with agreeing that lung screening could reduce chances of dying from cancer (see Table 5 ). Smoking status, beliefs about early presentation and being worried about wasting the doctor's time were not significantly associated with perceptions that lung screening could reduce lung cancer mortality.
| Lung screening to reduce mortality
| D ISCUSS I ON
To our knowledge, the present study was the first to test associations with lung cancer screening attitudes using quantitative survey methods in a population sample of adults over the age of 16.
Attitudes towards lung cancer screening were generally positive, with over 90% of survey respondents believing that there was benefit to lung cancer screening in terms of lung cancer outcomes and survival, and may encourage participation in lung cancer screening.
However, those who endorse negative beliefs about lung cancer may be more likely to avoid lung screening. Respondents who endorsed negative beliefs about lung cancer-reflecting fatalism, low perceived effectiveness of symptom presentation and negative views about treatment-were more likely to hold negative attitudes towards lung cancer screening. Smoking status was not significantly associated with attitudes towards lung cancer screening in the current study.
TA B L E 2
Frequencies and univariate analysis for lung screening attitude "I would be so worried about what might be found at lung cancer screening that I would prefer not to go" Our findings mirror those of previous studies that have examined participation in a colorectal cancer screening context, where over 90% of respondents in an Australian population-based study held positive beliefs about colorectal cancer screening. 20 In addition, positive beliefs about the benefits of colorectal cancer screening have been associated with increased anticipated uptake of screening 21 and participation in screening. 20, 22 The current study suggests that negative beliefs about lung cancer were associated with lung screening avoidance, particularly fatalism, suggesting that those who decline screening would prefer not to know if they have lung cancer, potentially due to fear of treatment and lung cancer death. Our findings are in line with previous research highlighting fear of lung cancer [12] [13] [14] and fatalism, including beliefs about the treatment for lung cancer 12, 15 as barriers to participation in lung cancer screening. It is likely that avoidance of lung screening and negative beliefs may reflect lung cancer stigma, 23 possibly due to the relationship between lung cancer and smoking, and poor lung cancer outcomes.
The absence of an observed association between smoking status and lung cancer screening attitudes in our study contradicts the findings of previous studies, which have highlighted more negative screening attitudes among current smokers. 12, 24 In addition, former smokers have been shown to be over-represented in lung cancer screening trials. 25, 26 Our contradictory findings are likely to reflect the limited representation of heavy smokers in our sample and con- 
